Bangladesh, Sept. 27 -- Envoy Textiles has reported a 2 per cent decline in profit to Tk 1.38 billion in FY26, mainly due to lower revenue caused by fewer working days during the year. Advertisement ... Read More
प्रतापगढ़ - कुंडा, सितम्बर 27 -- Pratapgarh Kunda News: पट्टी, हिन्दुस्तान संवाद। इलाके में शनिवार रात तेज हवा और बारिश के दौरान एक घर पर पेड़ गिर गया। इससे परिवार के दो सदस्यों के साथ छप्पर में बंधी द... Read More
Singapore, Sept. 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Open-Label Study of Rinzimetostat (ORIC-944) in Combination with Darolutam... Read More
Singapore, Sept. 27 -- The Health Sciences Authority received information related to the study titled 'An Interventional Phase 3, Open Label, Randomized Study To Evaluate Efficacy And Safety of PF-086... Read More
Singapore, Sept. 27 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Double-blind, Phase 3 Study of Pembrolizumab + Pemetrexed + Platinum Chemotherapy W... Read More
Singapore, Sept. 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Open-Label Study of Zoldonrasib (RMC-9805) Plus Daraxonrasib (RMC-6236) Ve... Read More
Singapore, Sept. 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, two-part, double-blind, randomized, placebo-controlled study to investigate the safety... Read More
Singapore, Sept. 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, double-blind, randomized, placebo controlled, 2-arm study to investigate the safety an... Read More
Singapore, Sept. 27 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Open-label, Multicentre, Randomised Study Comparing Consolidation Treatment with AZD... Read More
Singapore, Sept. 27 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Open-label, Multicenter, Phase 3 Study to Investigate Mocertatug Rezetecan with or ... Read More